Globus Medical Inc GMED
780 filings, 8 in the last 30 days
SEC filing indexWhat the 8-Ks said
1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Jul 21, 2025 CEO, CFO, COO or CAOCEO and CFO change “Scavilla notified the Chairman of the Board of Directors (the “Board”) of the Company of his resignation from the Board and from his positions as President and Chief Executive Officer of the Company, in each case effective July 18, 2025.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 51 events
- Nov 10, 2026 Planned sale TOBIN JAMES R (Director) gave notice of a planned sale of 41,666 shares worth about $3.1MForm 144, approximate sale date Nov 10, 2026
- Nov 5, 2026 Planned sale Kyle R. Kline (Chief Financial Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 25,493 shares, runs to Nov 30, 2027
- Nov 5, 2026 8-K Quarterly results, Other events8-K items 2.02, 8.01
- Nov 5, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Nov 4, 2026 Planned sale RHOADS ANN D (Director) gave notice of a planned sale of 5,000 shares worth about $425KForm 144, approximate sale date Nov 4, 2026, under a 10b5-1 plan adopted Jun 10, 2026
- Sep 15, 2026 Planned sale TOBIN JAMES R (Director) gave notice of a planned sale of 30,000 shares worth about $2.2MForm 144, approximate sale date Sep 15, 2026
- Aug 18, 2026 Planned sale ZARRILLI STEPHEN T (Director) gave notice of a planned sale of 25,000 shares worth about $2.2MForm 144, approximate sale date Aug 18, 2026
- Aug 6, 2026 Planned sale Ann D. Rhoads (a member of the Board) adopted a 10b5-1 trading planreported in the 10-Q, up to 25,000 shares, runs to Sep 10, 2027
- Aug 6, 2026 8-K Quarterly results8-K item 2.02
- Aug 6, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 5, 2026 Planned sale Davidar David D (Director) gave notice of a planned sale of 25,000 shares worth about $2.0MForm 144, approximate sale date Jun 5, 2026
- Jun 4, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 7, 2026 Planned sale Keith W. Pfeil (Chief Executive Officer and President) ended a 10b5-1 trading planreported in the 10-Q, up to 90,000 shares, runs to Jun 12, 2027
- May 7, 2026 8-K Quarterly results8-K item 2.02
- May 7, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 14, 2026 Planned sale DeFord John A (Former Director) gave notice of a planned sale of 30,000 shares worth about $2.8MForm 144, approximate sale date Apr 14, 2026
- Mar 23, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Feb 25, 2026 Planned sale Huller Kelly (Officer) gave notice of a planned sale of 20,000 shares worth about $1.9MForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Nov 12, 2025
- Feb 24, 2026 Planned sale Kelly G. Huller (Executive Vice President and General Counsel) adopted a 10b5-1 trading planreported in the 10-K, up to 67,500 shares, runs to Feb 7, 2027
- Feb 24, 2026 Planned sale Berachah Foundation (member of the Board) adopted a 10b5-1 trading planreported in the 10-K, up to 9,100 shares, runs to Dec 31, 2026
- Feb 24, 2026 Planned sale David D. Davidar (member of the Board) adopted a 10b5-1 trading planreported in the 10-K, up to 36,000 shares, runs to Dec 31, 2026
- Feb 24, 2026 8-K Quarterly results8-K item 2.02
- Feb 24, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 12, 2026 Planned sale Huller Kelly (Officer) gave notice of a planned sale of 10,000 shares worth about $876KForm 144, approximate sale date Feb 12, 2026, under a 10b5-1 plan adopted Nov 12, 2025
- Jan 8, 2026 Planned sale Norwalk Leslie V (Director) gave notice of a planned sale of 2,000 shares worth about $202KForm 144, approximate sale date Jan 8, 2026, under a 10b5-1 plan adopted Sep 12, 2025
- Jan 8, 2026 Planned sale Kline Kyle (Officer) gave notice of a planned sale of 3,594 shares worth about $363KForm 144, approximate sale date Jan 8, 2026, under a 10b5-1 plan adopted Aug 25, 2025
- Jan 7, 2026 8-K Quarterly results8-K item 2.02
- Dec 12, 2025 Planned sale Norwalk Leslie V (Director) gave notice of a planned sale of 4,000 shares worth about $355KForm 144, approximate sale date Dec 12, 2025, under a 10b5-1 plan adopted Sep 12, 2025
- Dec 1, 2025 Planned sale Kline Kyle (Officer) gave notice of a planned sale of 18,542 shares worth about $1.7MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 25, 2025
- Nov 25, 2025 Planned sale Huller Kelly (Officer) gave notice of a planned sale of 7,500 shares worth about $675KForm 144, approximate sale date Nov 25, 2025, under a 10b5-1 plan adopted Dec 4, 2024
- Nov 6, 2025 Planned sale Daniel T. Scavilla (President and Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 80,000 shares
- Nov 6, 2025 Planned sale Kyle R. Kline (Chief Financial Officer and Senior Vice President) adopted a 10b5-1 trading planreported in the 10-Q, up to 29,324 shares
- Nov 6, 2025 Planned sale Leslie V. Norwalk (Member of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 8,000 shares
- Nov 6, 2025 8-K Quarterly results8-K item 2.02
- Nov 6, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Aug 7, 2025 8-K Quarterly results8-K item 2.02
- Aug 7, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 21, 2025 Officer CEO and CFO changeScavilla notified the Chairman of the Board of Directors (the “Board”) of the Company of his resignation from the Board and from his positions as President and Chief Executive Officer of the Company, in each case effective July 18, 2025.
- Jun 5, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 15, 2025 8-K Other events8-K item 8.01
- May 8, 2025 Planned sale Keith Pfeil (Executive Vice President, Chief Operating Officer and Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 165,625 shares
- May 8, 2025 8-K Quarterly results8-K item 2.02
- May 8, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 3, 2025 8-K Acquisition or sale of assets completed, Regulation FD disclosure8-K items 2.01, 7.01
- Feb 20, 2025 Planned sale Ann D. Rhoads (Director) adopted a 10b5-1 trading planreported in the 10-K, up to 27,500 shares
- Feb 20, 2025 Planned sale Kelly Huller (Executive Vice President and General Counsel) adopted a 10b5-1 trading planreported in the 10-K, up to 37,500 shares
- Feb 20, 2025 Planned sale Daniel T. Scavilla (President and Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 80,000 shares
- Feb 20, 2025 8-K Quarterly results8-K item 2.02
- Feb 20, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 6, 2025 8-K Material agreement signed, Regulation FD disclosure, Other events8-K items 1.01, 7.01, 8.01
- Jan 8, 2025 8-K Quarterly results8-K item 2.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 12, 2026 | 4 | Insider trade |
| Nov 10, 2026 | 144 | Notice of planned insider sale |
| Nov 5, 2026 | 10-Q | Quarterly report |
| Nov 5, 2026 | 8-K | Quarterly results, Other events |
| Nov 5, 2026 | 4 | Insider trade |
| Nov 4, 2026 | 144 | Notice of planned insider sale |
| Oct 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Sep 16, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Aug 19, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 144 | Notice of planned insider sale |
| Aug 6, 2026 | 10-Q | Quarterly report |
| Aug 6, 2026 | 8-K | Quarterly results |
| Jul 28, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 144 | Notice of planned insider sale |
| Jun 4, 2026 | 8-K | Director or officer change, Shareholder vote results |
| May 27, 2026 | SD | Conflict minerals report |
| May 7, 2026 | 10-Q | Quarterly report |
| May 7, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 24, 2026 | DEFA14A | Extra proxy material |
| Apr 24, 2026 | DEF 14A | Proxy statement |
| Apr 14, 2026 | 144 | Notice of planned insider sale |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 23, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Feb 27, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 144 | Notice of planned insider sale |
| Feb 24, 2026 | 10-K | Annual report |
| Feb 24, 2026 | 8-K | Quarterly results |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 12, 2026 | 144 | Notice of planned insider sale |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 13, 2026 | 4/A | Insider trade (amended) |
| Jan 12, 2026 | 4 | Insider trade |
| Jan 12, 2026 | 4 | Insider trade |
| Jan 8, 2026 | 144 | Notice of planned insider sale |
| Jan 8, 2026 | 144 | Notice of planned insider sale |
| Jan 7, 2026 | 8-K | Quarterly results |
| Jan 5, 2026 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 12, 2025 | 144 | Notice of planned insider sale |
| Dec 10, 2025 | 4 | Insider trade |
| Dec 3, 2025 | 4 | Insider trade |
| Dec 1, 2025 | 144 | Notice of planned insider sale |
| Nov 28, 2025 | 4 | Insider trade |
| Nov 25, 2025 | 144 | Notice of planned insider sale |
| Nov 13, 2025 | 4 | Insider trade |
| Nov 13, 2025 | 4 | Insider trade |
| Nov 12, 2025 | 144 | Notice of planned insider sale |
| Nov 12, 2025 | 144 | Notice of planned insider sale |
| Nov 10, 2025 | 144 | Notice of planned insider sale |
| Nov 10, 2025 | 4 | Insider trade |
| Nov 7, 2025 | 144 | Notice of planned insider sale |
| Nov 6, 2025 | 10-Q | Quarterly report |
| Nov 6, 2025 | 8-K | Quarterly results |
| Sep 16, 2025 | 4 | Insider trade |
| Sep 15, 2025 | 144 | Notice of planned insider sale |
| Aug 27, 2025 | 4 | Insider trade |
| Aug 27, 2025 | 4 | Insider trade |
| Aug 27, 2025 | 3 | New insider |
| Aug 7, 2025 | 10-Q | Quarterly report |
| Aug 7, 2025 | 8-K | Quarterly results |
| Jul 21, 2025 | 8-K | Quarterly results, Director or officer change, Regulation FD disclosure |
| Jun 5, 2025 | 8-K | Director or officer change, Shareholder vote results |
| May 29, 2025 | SD | Conflict minerals report |
| May 15, 2025 | 8-K | Other events |
| May 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 8, 2025 | 10-Q | Quarterly report |
| May 8, 2025 | 8-K | Quarterly results |
| Apr 25, 2025 | DEFA14A | Extra proxy material |
| Apr 25, 2025 | DEF 14A | Proxy statement |
| Apr 24, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Apr 3, 2025 | 8-K | Acquisition or sale of assets completed, Regulation FD disclosure |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
| Mar 28, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GMED/export.csv") into a cell.